Advertisement
Screener

IRADIMED CORPORATION (IRMD) Deferred Revenue Recognized

2.8 / 5 stars · 68/120 Roast Me

IRADIMED CORPORATION Deferred Revenue Recognized

IRADIMED CORPORATION (IRMD) reported Deferred Revenue Recognized of $3.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Income Statement › Other Income

us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-31

  • IRADIMED CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $1.61M, a 112.38% increase year-over-year.
  • IRADIMED CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $759.00K.
Period endContract with Customer, Liability, Revenue Recognized 3 monthContract with Customer, Liability, Revenue Recognized 6 month
2026-06-30$3.11M
10-Q · filed 2026-07-31
2026-03-31$1.61M
10-Q · filed 2026-05-01
2025-06-30$1.71M
10-Q · filed 2026-07-31
2025-03-31$759.00K
10-Q · filed 2026-05-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02